4.7 Article

Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias

期刊

BRAIN
卷 135, 期 -, 页码 2798-2808

出版社

OXFORD UNIV PRESS
DOI: 10.1093/brain/aws211

关键词

Alzheimer's disease; dementia with Lewy bodies; Parkinson's disease dementia; striatum; I-123-FP-CIT; SPECT; neuropathology

资金

  1. Medical Research Council
  2. UK NIHR Biomedical Research Centre for Ageing and Age-Related Disease
  3. Biomedical Research Unit for Lewy body dementia awards
  4. Dunhill Medical Trust [R173/1110]
  5. UK Medical Research Council [G0400074]
  6. MRC [G1100540, G0400074, G0900652, G0502157] Funding Source: UKRI
  7. Alzheimers Research UK [ART-EG2010A-1] Funding Source: researchfish
  8. Medical Research Council [G0400074, G0502157, G1100540, G0900652] Funding Source: researchfish
  9. The Dunhill Medical Trust [R173/1110] Funding Source: researchfish

向作者/读者索取更多资源

Investigation of dopaminergic transporter loss in vivo using I-123-N-fluoropropyl-2 beta-carbomethoxy-3 beta-(4-iodophenyl) nortropane single photon emission computed tomography has been widely used as a diagnostic aid in Lewy body disease. However, it is not clear whether the pathological basis for the imaging changes observed reflects loss of dopaminergic transporter expressing neurons because of cell death or dysfunctional neurons due to possible nigral and/or striatal neurodegenerative pathology. We aimed to investigate the influence of nigral neuronal loss as well as nigral (alpha-synuclein, tau) and striatal (alpha-synuclein, tau, amyloid beta) pathology on striatal uptake in a cohort of autopsy-confirmed Alzheimer's disease (n = 4), dementia with Lewy bodies (n = 7) and Parkinson's disease dementia (n = 12) cases. Subjects underwent ante-mortem dopaminergic scanning and post-mortem assessments (mean interval 3.7 years). Striatal binding (caudate, anterior and posterior putamen) was estimated using region of interest procedures while quantitative neuropathological measurements of alpha-synuclein, tau and amyloid beta were carried out. Similarly, nigral neuronal density was assessed quantitatively. Stepwise linear regression was performed to identify significant pathological predictors of striatal binding. In all striatal regions, image uptake was associated with nigral dopaminergic neuronal density (P <= 0.04) but not alpha-synuclein (P >= 0.46), tau (P >= 0.18) or amyloid beta (P >= 0.22) burden. The results suggest that reduced uptake in vivo may be influenced considerably by neuronal loss rather than the presence of pathological lesions, in particular those related to Alzheimer's disease and Lewy body dementias. However, dysfunctional nigral neurons may have an additional effect on striatal uptake in vivo but their respective role remains to be elucidated.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia

Kirsty E. McAleese, Sean J. Colloby, Alan J. Thomas, Safa Al-Sarraj, Olaf Ansorge, James Neal, Federico Roncaroli, Seth Love, Paul T. Francis, Johannes Attems

Summary: The aged brain often exhibits multiple pathologies, rather than a single pathology, and the presence of multiple pathologies can significantly worsen cognitive decline, increasing the risk of transitioning from mild cognitive impairment to dementia.

ALZHEIMERS & DEMENTIA (2021)

Article Health Care Sciences & Services

Introduction

Rebecca Gathercole, Rosie Bradley, Emma Harper, Lucy Davies, Lynn Pank, Natalie Lam, Anna Davies, Emma Talbot, Emma Hooper, Rachel Winson, Bethany Scutt, Victoria Ordonez Montano, Samantha Nunn, Grace Lavelle, Matthew Lariviere, Shashivadan Hirani, Stefano Brini, Andrew Bateman, Peter Bentham, Alistair Burns, Barbara Dunk, Kirsty Forsyth, Chris Fox, Catherine Henderson, Martin Knapp, Iracema Leroi, Stanton Newman, John O'Brien, Fiona Poland, John Woolham, Richard Gray, Robert Howard

Summary: This report includes parts reproduced with permission from the respective authors and published under open access licenses, allowing for free distribution and reproduction with proper citation. Minor modifications and formatting changes may have been made to the original text.

HEALTH TECHNOLOGY ASSESSMENT (2021)

Article Clinical Neurology

Molecular pathology and synaptic loss in primary tauopathies: an F-18-AV-1451 and C-11-UCB-J PET study

Negin Holland, Maura Malpetti, Timothy Rittman, Elijah E. Mak, Luca Passamonti, Sanne S. Kaalund, Frank H. Hezemans, P. Simon Jones, George Savulich, Young T. Hong, Tim D. Fryer, Franklin Aigbirhio, John T. O'Brien, James B. Rowe

Summary: The relationship between in vivo synaptic density and molecular pathology in primary tauopathies, especially in progressive supranuclear palsy and corticobasal degeneration, is investigated in this study. It is found that there is a biphasic correlation between synaptic density and molecular pathology, with regions rich in synapses more vulnerable to pathological aggregates accumulation, followed by synaptic loss as a response to the molecular pathology. These findings contribute to a better understanding of the pathophysiology of primary tauopathies and may inform the design of future clinical trials.
Article Neurosciences

High coffee consumption, brain volume and risk of dementia and stroke

Kitty Pham, Anwar Mulugeta, Ang Zhou, John T. O'Brien, David J. Llewellyn, Elina Hypponen

Summary: The study found that high coffee consumption was associated with smaller total brain volumes and increased odds of dementia, but had less evidence for an association with stroke.

NUTRITIONAL NEUROSCIENCE (2022)

Article Clinical Neurology

Functional and structural brain network correlates of visual hallucinations in Lewy body dementia

Ramtin Mehraram, Luis R. Peraza, Nicholas R. E. Murphy, Ruth A. Cromarty, Sara Graziadio, John T. O'Brien, Alison Killen, Sean J. Colloby, Michael Firbank, Li Su, Daniel Collerton, John-Paul Taylor, Marcus Kaiser

Summary: This study investigates visual hallucinations in Lewy body dementia using EEG source localization and diffusion tensor imaging. The findings suggest consistent weakened connectivity within the visual ventral network and between this network and other networks in hallucinating patients. Structural analysis reveals affected white matter streamlines connecting cortical regions to the nucleus basalis of Meynert and the thalamus in hallucinating patients. This study provides empirical evidence for existing models of visual hallucinations in Lewy body dementia.
Article Neurosciences

A synergistic core for human brain evolution and cognition

Andrea Luppi, Pedro A. M. Mediano, Fernando E. Rosas, Negin Holland, Tim D. Fryer, John T. O'Brien, James B. Rowe, David K. Menon, Daniel Bor, Emmanuel A. Stamatakis

Summary: This study decomposes neural information into synergistic and redundant components, showing the role of core brain regions in supporting higher cognition and demonstrating that humans leverage synergistic information more than macaques. The study also reveals the distinct roles of redundant and synergistic interactions in neural information processing.

NATURE NEUROSCIENCE (2022)

Article Geriatrics & Gerontology

Trazodone and patient outcomes in dementia-Limitations of naturalistic cohort data

Emad Sidhom, Mc Stephen Padilla, Jonathan Lewis, Simon White, John T. O'Brien, Giovanna R. Mallucci, Benjamin R. Underwood

Summary: The unfolded protein response has been identified as an important pathway and target for therapeutic intervention in neurodegeneration. However, the antidepressant trazodone, which has been proposed to act on this pathway, did not show disease modifying effects in previous studies. A new study examining electronic patient records of dementia patients in Cambridgeshire UK found that trazodone is rarely prescribed and at a lower dose than predicted. Patients prescribed trazodone had higher levels of neuropsychiatric symptoms and were in a late stage of the disease, suggesting that therapeutic intervention may no longer be effective.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2022)

Article Clinical Neurology

Do Regions of Increased Inflammation Progress to New White Matter Hyperintensities?: A Longitudinal Positron Emission Tomography-Magnetic Resonance Imaging Study

Daniel J. Tozer, Robin B. Brown, Jessica Walsh, Young T. Hong, Guy B. Williams, John T. O'Brien, Franklin I. Aigbirhio, Tim D. Fryer, Hugh S. Markus

Summary: Recent studies have found evidence of increased microglial activation, indicating inflammation, in cerebral small vessel disease. However, it is unclear whether these areas of neuroinflammation progress to tissue damage. This study showed that white matter destined to become white matter hyperintensities already exhibited signs of altered inflammation at baseline.

STROKE (2023)

Article Medicine, General & Internal

Association between antidementia medication use and mortality in people diagnosed with dementia with Lewy bodies in the UK: A retrospective cohort study

Shanquan Chen, Annabel C. Price, Rudolf N. Cardinal, Sinead Moylett, Anne D. Kershenbaum, James Fitzgerald, Christoph Mueller, Robert Stewart, John T. O'Brien

Summary: This study aimed to investigate the association between the use of acetylcholinesterase inhibitors (AChEIs) and/or memantine in patients with dementia with Lewy bodies (DLBs) and their hospital admissions and mortality rates. The results showed that the use of AChEIs and/or memantine was associated with a reduced risk of death and shorter hospital stays for DLB patients.

PLOS MEDICINE (2022)

Article Geriatrics & Gerontology

Mortality rates and proximal causes of death in patients with Lewy body dementia versus Alzheimer's disease: A longitudinal study using secondary care mental health records

Anne D. Kershenbaum, Annabel C. Price, Rudolf N. Cardinal, Shanquan Chen, James M. Fitzgerald, Jonathan Lewis, Sinead Moylett, John T. O'Brien

Summary: Previous studies have shown reduced survival in Lewy body dementia (LBD) compared to Alzheimer's disease (AD), but the reasons for this are not known. This study aimed to identify cause of death categories accounting for the reduced survival in LBD. The findings indicated that PDD and DLB patients had higher hazard ratios for death compared to AD patients.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2023)

Review Biochemistry & Molecular Biology

The use of neuroimaging techniques in the early and differential diagnosis of dementia

Leonidas Chouliaras, John T. O'Brien

Summary: Dementia is a major cause of disability and death worldwide, with no disease modifying treatment available for common types such as Alzheimer's disease, Vascular dementia, Lewy Body Dementia, and Frontotemporal dementia. Early and accurate diagnosis of dementia subtype is crucial for improving clinical care and developing better treatments. Structural and molecular imaging methods, particularly multimodal magnetic resonance imaging (MRI) and positron emission tomography imaging (PET), have provided insight into the pathophysiology of neurodegenerative dementias and are increasingly being used for early and accurate diagnosis. However, there are still gaps in imaging tracers for certain protein abnormalities, and more extensive diagnostic imaging studies are needed.

MOLECULAR PSYCHIATRY (2023)

Article Clinical Neurology

Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body dementia: A longitudinal study

Laura M. Wright, Paul C. Donaghy, David J. Burn, John -Paul Taylor, John T. O'Brien, Alison J. Yarnall, Fiona E. Matthews, Michael J. Firbank, Alan J. Thomas, Rachael A. Lawson

Summary: There is a limited longitudinal relationship between neuropsychiatric symptoms (NPS) and cognitive decline in prodromal Lewy body dementias (LBD). Core neuropsychiatric symptoms are not strongly associated with cognition, suggesting different underlying neuropathological mechanisms.

PARKINSONISM & RELATED DISORDERS (2023)

Article Clinical Neurology

Genetic risks of Alzheimer's by APOE and MAPT on cortical morphology in young healthy adults

Weijie Huang, Jianmin Zeng, Lina Jia, Dajiang Zhu, John O'Brien, Craig Ritchie, Ni Shu, Li Su

Summary: Genetic risk factors such as APOE ε4 and MAPT A allele are associated with changes in amyloid and tau pathways and cortical morphology in young healthy adults. Machine learning models showed that using all cortical features could accurately classify individuals with genetic risks of dementia. APOE ε4 carriers exhibited a more convoluted and thinner cortex across the cerebral cortex, while MAPT A allele carriers showed similar patterns in regions vulnerable to early tau pathology. There was a synergetic effect between APOE ε4 and MAPT A allele, with carriers of both risk factors showing the most deviation from the typical cortical pattern.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Fluid-attenuated inversion recovery magnetic resonance imaging textural features as sensitive markers of white matter damage in midlife adults

Maria-Eleni Dounavi, Audrey Low, Graciela Muniz-Terrera, Karen Ritchie, Craig W. Ritchie, Li Su, Hugh S. Markus, John T. O'Brien

Summary: In healthy midlife adults, Dounavi and Low demonstrate that fluid-attenuated inversion recovery (FLAIR) MRI textural measures emerging from white matter hyperintensities (WMHs) and normal appearing white matter, related to WMH volume, reaction time and dementia risk. The observed associations suggest that FLAIR textural analysis might capture subtle white matter microstructural alterations.

BRAIN COMMUNICATIONS (2022)

Article Clinical Neurology

Microglial activation and blood-brain barrier permeability in cerebral small vessel disease

Jessica Walsh, Dan J. Tozer, Hasan Sari, Young T. Hong, Anna Drazyk, Guy Williams, N. Jon Shah, John T. O'Brien, Franklin Aigbirhio, Gary Rosenberg, Tim D. Fryer, Hugh S. Markus

Summary: Cerebral small vessel disease is a major cause of stroke and dementia. The study found that in sporadic SVD patients, microglial activation and increased blood-brain barrier permeability occur separately in spatial terms. No evidence of increased blood-brain barrier permeability was found in CADASIL.
暂无数据